Plenary Session VII: Controversies - Six Thought Stimulating Abstracts | Recorded at the AATS Mitral Conclave 2025

Plenary Session VII: Controversies – Six Thought-Stimulating Abstracts, recorded at the AATS Mitral Conclave 2025, features six data-driven presentations examining contemporary debates in mitral and tricuspid valve surgery. This session explores emerging evidence related to simplified repair strategies, prosthesis selection, minimally invasive and robotic approaches, and outcomes following prior transcatheter intervention. Faculty present long-term and multicenter data highlighting variability in techniques, institutional experience, and procedural volume, followed by expert discussion of their clinical implications. The plenary is designed to support critical evaluation of evolving evidence and to inform patient selection, procedural planning, and long-term management decisions in modern valvular practice.

Featured Abstract Presentations:

  • 'Less Is More': Isolated Annuloplasty for Bileaflet Prolapse in Myxomatous Mitral Valve Disease - A Simplified Approach with Durable Results
  • Low Incidence of Postoperative Pacemaker Implantation Following Tricuspid Valve Repair: Impact of a Contemporary Tricuspid Valve Annuloplasty Device in a Multi-Center Study
  • Long-term Outcomes of Mechanical versus Bioprosthetic Mitral Valve Replacement: A Province-Wide Cohort Study
  • Evolution of Minimally Invasive Mitral Valve Repair: The 30-year Leipzig Experience
  • The Association of Volume of Robotic Mitral Repair on Early and Late Outcomes in the United States
  • Successful Minimally-Invasive Fully Endoscopic Surgical Mitral Valve Repair After Transapical Chord Implantation and Transseptal Mitral Edge-to-Edge Repair with Five Clips Implanted
Course summary
Available credit: 
  • 1.50 ABS Accredited CME

    Successful completion of this CME activity, [which includes participation in the evaluation component], enables the learner to earn credit toward the CME [and Self-Assessment] requirement(s) of the American Board of Surgery Continuous Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
  • 1.50 ABTS Accredited CME
    Successful completion of this CME activity, [which includes participation in the evaluation component], enables the learner to earn credit toward the CME [and Self-Assessment / Patient Safety / Performance in Practice requirements] of the American Board of Thoracic Surgery’s Maintenance of Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABTS credit.
  • 1.50 AMA PRA Category 1 Credit(s)™
    The American Association for Thoracic Surgery designates this for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.50 Participation
Course opens: 
12/10/2025
Course expires: 
12/10/2028
Cost:
$200.00

Disclosure of Financial Relationships

The individuals in control of content for this activity did not have any relevant relationships with ACCME defined ineligible companies to disclose unless listed below. All relevant relationships were mitigated prior to the start of the activity according to The Standards for Integrity and Independence in Accredited Continuing Education.

View Disclosure Listing

 

 

Purpose (Desired Learning Outcome) 

Following this session, learners will be able to evaluate emerging clinical evidence related to mitral and tricuspid valve surgery and apply expert informed insights to patient selection and procedural decision making.

ACCME Accreditation Statement

The American Association for Thoracic Surgery is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement 

The American Association for Thoracic Surgery designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Commercial Support

The 2025 AATS International Thoracic Surgical Oncology Summit received commercial support from:

  • Abbott

Available Credit

  • 1.50 ABS Accredited CME

    Successful completion of this CME activity, [which includes participation in the evaluation component], enables the learner to earn credit toward the CME [and Self-Assessment] requirement(s) of the American Board of Surgery Continuous Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
  • 1.50 ABTS Accredited CME
    Successful completion of this CME activity, [which includes participation in the evaluation component], enables the learner to earn credit toward the CME [and Self-Assessment / Patient Safety / Performance in Practice requirements] of the American Board of Thoracic Surgery’s Maintenance of Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABTS credit.
  • 1.50 AMA PRA Category 1 Credit(s)™
    The American Association for Thoracic Surgery designates this for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.50 Participation

Price

Cost:
$200.00
Please login or register to take this course.